SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-20-000065
Filing Date
2020-05-15
Accepted
2020-05-15 18:34:50
Documents
1
Period of Report
2020-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158958207301515.html 4  
1 FORM 4 wf-form4_158958207301515.xml 4 5928
  Complete submission text file 0001479290-20-000065.txt   7272
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Russell Angus C. (Reporting) CIK: 0001534002 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 20887274